腫瘍の微小環境を経口 HO-1 阻害剤で加熱する

Cait A McAlindon¹, Rachael A Clark¹

¹Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Science immunology

|September 5, 2025

まとめ

経口投与可能な新しいヘム酸素酶-1 (HO-1) 阻害剤は,マウスのCD8T細胞の増殖を促し,腫瘍のクリアランスを改善することで,化学療法効果を向上させます.

科学分野:

免疫学
薬理学について
腫瘍学

背景:

化学療法に対する耐性は癌治療における大きな課題です
ヘム酸素酶-1 (HO-1) は腫瘍の進行と免疫抑制に関与しています.
HO-1をターゲットにすることで,抗がん療法を強化する戦略が生まれます.

研究の目的:

新しい経口生物利用可能な HO-1 阻害剤の有効性を評価する.
化学療法後の腫瘍クリアランスに対する抑制剤の効果を調査する.
根底にある免疫的メカニズム,特にCD8 T細胞の関与を決定する.

主な方法:

マウスのがんモデルに経口で生体利用可能なHO-1阻害剤を投与する.
標準的な化学療法剤との併用療法
腫瘍内の免疫細胞,特にCD8T細胞の浸透を評価するためのフロー細胞測定と免疫ヒスト化学.

主要な成果:

HO-1 阻害剤は,化学療法と併用すると,腫瘍のクリアランスを有意に増加させました.
治療により,腫瘍組織にCD8T細胞の徴集と浸透が顕著に増加した.
この阻害剤は,口服による良好な生物利用性を示し,動物モデルではよく耐えた.

結論:

化学療法に対する耐性を克服するための有望な戦略です.
HO-1抑制により抗腫瘍免疫が強化される重要なメカニズムです.
このアプローチは様々な癌の患者さんの治療結果を改善する可能性を秘めています

さらに関連する動画

08:52

Intravital Microscopy of Tumor-associated Vasculature Using Advanced Dorsal Skinfold Window Chambers on Transgenic Fluorescent Mice

Published on: January 19, 2018

14.1K

13:41

Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model

Published on: January 13, 2023

2.5K

関連する概念動画

02:17

The Tumor Microenvironment

6.8K

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...

6.8K

01:27

Tumor Immunotherapy

658

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

658

02:49

Cancer Therapies

7.9K

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

7.9K

02:07

Tumor Progression

6.5K

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

6.5K

02:57

Targeted Cancer Therapies

7.8K

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...